This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Fibroblast growth factor receptor 3D receptor
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
*FGFR1 | *FGFR1 | ||
| - | *''FGFR1 tyrosine kinase domain residues 458-765'' | + | *''FGFR1 tyrosine kinase domain (TKD) residues 458-765'' |
**[[4uwy]], [[6mzq]] – hFGFR1 TKD - human<br /> | **[[4uwy]], [[6mzq]] – hFGFR1 TKD - human<br /> | ||
**[[1fgk]], [[3kxx]], [[3ky2]], [[4rwi]], [[5flf]] – hFGFR1 TKD (mutant) - human <br /> | **[[1fgk]], [[3kxx]], [[3ky2]], [[4rwi]], [[5flf]] – hFGFR1 TKD (mutant) - human <br /> | ||
| - | **[[4wun]], [[5am6]], [[5ew8]], [[5o49]], [[5o4a]], [[6mzw]], [[6c1o]] – hFGFR1 TKD + inhibitor <br /> | + | **[[4wun]], [[5am6]], [[5ew8]], [[5o49]], [[5o4a]], [[6mzw]], [[6c1o]], [[6mzq]], [[6mzw]] – hFGFR1 TKD + inhibitor <br /> |
| - | **[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]], [[5b7v]], [[5am7]], [[4rwj]], [[4rwk]], [[4rwl]], [[4uwb]], [[4uwc]], [[4zsa]], [[5uq0]], [[5vnd]], [[5ur1]], [[6p68]], [[6p69]], [[6c18]], [[6c19]], [[6c1b]], [[6c1c]], [[5z0s]] – hFGFR1 TKD (mutant) + inhibitor <br /> | + | **[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]], [[5b7v]], [[5am7]], [[4rwj]], [[4rwk]], [[4rwl]], [[4uwb]], [[4uwc]], [[4zsa]], [[5uq0]], [[5vnd]], [[5ur1]], [[6p68]], [[6p69]], [[6c18]], [[6c19]], [[6c1b]], [[6c1c]], [[5z0s]], [[6agx]], [[6itj]], [[6nvl]], [[6p68]], [[6p69]] – hFGFR1 TKD (mutant) + inhibitor <br /> |
**[[5zv2]] – hFGFR1 TKD (mutant) + anti-cancer drug<br /> | **[[5zv2]] – hFGFR1 TKD (mutant) + anti-cancer drug<br /> | ||
**[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | **[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | ||
| Line 18: | Line 18: | ||
**[[3gql]] – hFGFR1 TKD (mutant) + substrate <br /> | **[[3gql]] – hFGFR1 TKD (mutant) + substrate <br /> | ||
| - | *''FGFR1 ligand-binding domain D1 residues 35-208'' | + | *''FGFR1 ligand-binding domain (LBD) D1 residues 35-208'' |
**[[2cr3]] – hFGFR1 LBD D1 - NMR<br /> | **[[2cr3]] – hFGFR1 LBD D1 - NMR<br /> | ||
**[[2ckn]] – FGFR1 LBD D1 – mouse - NMR<br /> | **[[2ckn]] – FGFR1 LBD D1 – mouse - NMR<br /> | ||
| - | *''FGFR1 D1 complex with FGF'' | + | *''FGFR1 LBD D1 complex with FGF'' |
**[[5w59]] – hFGFR1 LBD D1 + FGF9<br /> | **[[5w59]] – hFGFR1 LBD D1 + FGF9<br /> | ||
| - | *''FGFR1 D2,D3 residues 142-365 complex with FGF'' | + | *''FGFR1 LBD D2,D3 residues 142-365 complex with FGF'' |
**[[3ojv]] – hFGFR1 LBD D2,D3 (mutant) + hFGF1 - human <br /> | **[[3ojv]] – hFGFR1 LBD D2,D3 (mutant) + hFGF1 - human <br /> | ||
| Line 46: | Line 46: | ||
**[[3cly]] – hFGFR2 TKD (mutant) with PTR + ACP <br /> | **[[3cly]] – hFGFR2 TKD (mutant) with PTR + ACP <br /> | ||
**[[5eg3]] – hFGFR2 TKD (mutant) with PTR + ACP + phospholipase C γ<br /> | **[[5eg3]] – hFGFR2 TKD (mutant) with PTR + ACP + phospholipase C γ<br /> | ||
| - | **[[3ri1]] – hFGFR2 TKD + inhibitor<br /> | + | **[[3ri1]], [[6lvk]], [[6lvl]] – hFGFR2 TKD + inhibitor<br /> |
*''FGFR2 ligand-binding domain'' | *''FGFR2 ligand-binding domain'' | ||
| Line 70: | Line 70: | ||
**[[3grw]] – hFGFR3 LBD D2,D3 + antibody<br /> | **[[3grw]] – hFGFR3 LBD D2,D3 + antibody<br /> | ||
**[[2lzl]] – hFGFR3 residues 357-399 – NMR<br /> | **[[2lzl]] – hFGFR3 residues 357-399 – NMR<br /> | ||
| - | **[[4k33]] – hFGFR3 | + | **[[4k33]] – hFGFR3 TKD (mutant)<br /> |
| + | **[[6lvm]] – hFGFR3 TKD + inhibitor<br /> | ||
| + | **[[6pnx]] – hFGFR3 TKD (mutant) + ACP<br /> | ||
*''FGFR3 complex with FGF'' | *''FGFR3 complex with FGF'' | ||
| Line 82: | Line 84: | ||
**[[4tye]], [[4tyg]], [[4tyi]], [[4tyj]] – hFGFR4 TKD <br /> | **[[4tye]], [[4tyg]], [[4tyi]], [[4tyj]] – hFGFR4 TKD <br /> | ||
**[[4qqj]], [[4qqt]] – hFGFR4 TKD (mutant) <br /> | **[[4qqj]], [[4qqt]] – hFGFR4 TKD (mutant) <br /> | ||
| - | **[[5jkg]], [[5nwz]], [[5nud]] – hFGFR4 TKD + inhibitor<br /> | + | **[[5jkg]], [[5nwz]], [[5nud]], [6nvg]], [[6nvh]], [[6nvi]], [[6nvj]], [[6nvk]], [[6v9c]] – hFGFR4 TKD + inhibitor<br /> |
| - | **[[6jpj]], [[5xff]], [[5xfj]] – hFGFR4 TKD (mutant) + inhibitor<br /> | + | **[[6jpj]], [[5xff]], [[5xfj]], [[6iuo]], [[6iup]], [[6jpe]], [[6jpj]] – hFGFR4 TKD (mutant) + inhibitor<br /> |
**[[4qrc]], [[4r6v]], [[4qqc]], [[4qq5]], [[4uxq]], [[4xcu]] – hFGFR4 TKD (mutant) + irreversible inhibitor<br /> | **[[4qrc]], [[4r6v]], [[4qqc]], [[4qq5]], [[4uxq]], [[4xcu]] – hFGFR4 TKD (mutant) + irreversible inhibitor<br /> | ||
| - | + | **[[6j6y]] – hFGFR4 LBD D2 + antibody<br /> | |
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 08:14, 28 July 2020
3D structures of fibroblast growth factor receptor
Updated on 28-July-2020
